Skip to content

Clinical trials

Completed Non-alcoholic Fatty Liver Disease trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Completed Country / region: South Korea Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20111
20131
20141
20151
20163
20171
20182
20193
20205
20214
20222
20235
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yonsei University5
J2H Biotech3
AstraZeneca2
Chuncheon Sacred Heart Hospital2
Korea University2
Korea University Guro Hospital2
Merck Sharp & Dohme LLC2
PharmaKing2
AngioLab, Inc.1
Boehringer Ingelheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease33
Fatty Liver4
Diabetes Mellitus, Type 23
Liver Cirrhosis2
Liver Diseases2
Atherosclerosis1
Digestive System Diseases1
Dyslipidemias1
Insulin Resistance1
Metabolic Syndrome1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.